We are live on ! Find out more
TA

Tamarack Advisers Portfolio holdings

AUM $2.12M
1-Year Est. Return 58.09%
This Fund
S&P 500
This Quarter Est. Return
-9.99%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$173M
AUM Growth
-$38.5M
Cap. Flow
-$5.29M
Cap. Flow %
-3.06%
Top 10 Hldgs %
57.59%
Holding
58
New
12
Increased
14
Reduced
11
Closed
17

Top Buys

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$7.43M
2
MDRX
Veradigm Inc. Common Stock
MDRX
+$6.54M
3
LH icon
Labcorp
LH
+$6.2M
4
UTHR icon
United Therapeutics
UTHR
+$6.1M
5
THC icon
Tenet Healthcare
THC
+$5.92M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$8.32M
2
MRK icon
Merck
MRK
+$7.09M
3
CVS icon
CVS Health
CVS
+$5.06M
4
EXEL icon
Exelixis
EXEL
+$4.53M
5
GILD icon
Gilead Sciences
GILD
+$4.46M

Sector Composition

Rank Sector Weight
1 Healthcare 95.07%
2 Consumer Staples 2.98%
3 Technology 0.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
51
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
– –
-4,000
Closed -$1.81M
UNH icon
52
UnitedHealth
UNH
$376B
– –
-4,000
Closed -$2.04M
VTRS icon
53
CALL
Viatris
VTRS
$20.4B
– –
-3,000
Closed -$33K
PDCO
54
DELISTED
Patterson Companies, Inc.
PDCO
– –
-50,000
Closed -$1.62M
CVET
55
DELISTED
Covetrus, Inc. Common Stock
CVET
– –
-129,000
Closed -$2.17M
1 2
3

Similar funds

SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
DU
Delphia (USA) Toronto, Ontario, Canada $445K AUM 28.82% 1-Year Est. Return

Tamarack Advisers's Q2 2022 Portfolio in Review

As of Q2 2022, Tamarack Advisers held 58 positions worth $173M, down 18% from $211M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Tamarack Advisers withdrew a net $5.29M in Q2 2022, closing 17 positions and reducing 11 holdings. Its most notable exit was Medtronic, an estimated $8.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 90% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, Tamarack Advisers opened a new position in Perrigo worth $8.11M.

  • Tamarack Advisers's largest Q2 2022 buy was Perrigo: 200,000 shares worth $8.11M.
  • Tamarack Advisers added most to Veradigm Inc. Common Stock in Q2 2022, an estimated $6.54M increase.
  • Tamarack Advisers's biggest Q2 2022 reduction was Merck, cutting an estimated $7.09M.
  • Tamarack Advisers fully exited Medtronic in Q2 2022, selling an estimated $8.32M.
  • Tamarack Advisers's ten largest holdings make up 58% of its $173M portfolio in Q2 2022.
  • Tamarack Advisers opened 12 new positions and closed 17 in Q2 2022.
  • Tamarack Advisers's portfolio value fell 18% quarter-over-quarter to $173M.

Based on Tamarack Advisers's 13F filing for Q2 2022, filed 16 Aug 2022.